Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

by Tonneijck, Lennart, Smits, Mark M., Muskiet, Marcel H. A., Hoekstra, Trynke, Kramer, Mark H. H., Danser, A. H. Jan, Diamant, Michaela, Joles, Jaap A., van Raalte, Daniël H.
Published 2016

Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in...

by Smits, Mark M, Tonneijck, Lennart, Muskiet, Marcel H A, Hoekstra, Trynke, Kramer, Mark H H, Pieters, Indra C, Cahen, Djuna L, Diamant, Michaela, van Raalte, Daniël H
Published 2015

Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients

by Smits, Mark M., Tonneijck, Lennart, Muskiet, Marcel H.A., Hoekstra, Trynke, Kramer, Mark H.H., Diamant, Michaela, Nieuwdorp, Max, Groen, Albert K., Cahen, Djuna L., van Raalte, Daniël H.
Published 2016